Siemens Assists Lung Nodule Detection with FDA Clearance

Siemens Medical Solutions has received the approval letter from the U.S. FDA for its syngo Lung CAD device, which is designed to assist radiologists in the detection of solid lung nodules in computed tomography (CT) examinations of the chest.
syngo Lung CAD was validated on the use of CAD in thoracic CT examinations in the largest multicenter, multireader study performed to date. Each of the nearly 200 cases was reviewed by 17 radiologists using data from four leading medical centers in the U.S. The use of syngo Lung CAD as a second reader helped all participating radiologists to significantly increase their detection accuracy for clinically significant lung nodules.
"syngo Lung CAD adds significant new capabilities to the syngo LungCARE CT application by increasing the medical professional's ability to catch more pulmonary nodules during the review of CT studies with hundreds of images," said Louise McKenna Ph.D., M.B.A., global clinical marketing manager, Onco CT, CT Division, Siemens Medical Solutions.